18:00 Tue 21 Sep 2021
Transaction in own shares
Arix Bioscience PLC (ARIX)
Arix Bioscience plc
Transaction in own shares
Arix intends to retain the purchased shares in treasury. Following settlement of the above purchase, Arix will have 129,928,800 ordinary shares of In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into [ENDS] For more information on Arix, please contact:
Arix Bioscience plc +44 (0)20 7290 1050
Optimum Strategic Communications Mary Clark, +44 (0)20 8078 4357
About Arix Bioscience plc Arix Bioscience plc is a global venture capital company focused on inve We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com
|
ISIN: | GB00BD045071 |
Category Code: | POS |
TIDM: | ARIX |
LEI Code: | 213800OVT3AHQCXNIX43 |
OAM Categories: | 2.4. Acquisition or disposal of the issuer's own shares |
Sequence No.: | 122684 |
EQS News ID: | 1235060 |
End of Announcement | EQS News Service |
|
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE